logo
phone+91-79-41078000
mailinfo@lincolnpharma.com
  • Home
  • About us
    • FROM MD’s Desk
    • Mission Vission
    • Corporate Profile
    • Milestones
    • Corporate Film
    • Code of Conduct
  • Marketing
    • Domestic
      • New Launch
      • Patent
      • Division
      • Distribution Network
    • International
      • Awards & Certificate
      • Products
      • Contact Info
      • Countries
  • Manufacturing
    • Introduction
    • Facility
    • Compliance
    • Quality Control
    • Quality Assurance
    • Awards
    • Intellectual Capital
  • Research & Development
    • R & D CENTER
    • Department
    • Infrastructure
    • Development Portfolio
    • Business Opportunities
  • Career
  • Our Activities
    • Corporate social responsibility
    • For healthcare professionals only
    • Adverse event section for drugs
  • Blog
  • Publications
  • Investors

INVESTORS

  • Board of Directors
  • Code of Conduct
  • Investor Information
  • TERMS AND CONDITION OF APPOINTMENT OF INDEPENDENT DIRECTOR
  • Notice Regarding Change of RTA.
  • PRESS RELEASE
  • Press Release -- Launches Vaginal Spray
  • Press Release on NDDS formulation Ondansetron Oral Spray (Domi Up)
  • A.G.M.-2016 Scrutinizer Report
  • AGM-2017 Scrutinizer Report
  • Press Release for Awardwd Patent Antimalarial Drug.
  • Details of Nodal Officer under IEPF
  • Appointment of Director on the Board of the Company
  • Intimation of Regulation 30 of SEBI, LODR
  • DEMATERIALIZATION OF PHYSICAL SECURITIES
  • A.G.M. - 2018 - Scrutinizer Report
  • Code of Practices and Procedures For Fair Disclosure of Unpublished Price Sensitive Information
  • A.G.M. -2019 SCRUTINIZER REPORT
  • Press Release on Patent
  • Letter for Change in officials of Determining the Materiality of Events
  • Media Release on EU GMP
  • Disclousre on Material Impact of CoVID-19
  • Media Release on Vitamin C Launch
  • Intimation under Reg 30 of SEBI (LODR)
  • Lincoln Pharmaceuticals Ltd
  • About Us
  • Investors
  • Annual_Report
  • Shareholding_Pattern
  • Financial_Results
  • Corporate_Governance_Reports
  • Company_Policy
  • NOTICE_OF_BOARD_MEETING
  • Subsidiary_Company_Annual_Reports
  • Unpaid_Dividend_Data
  • Business_Presentation
  • LPL_IEPF_SUSPENSE_ACCOUNT
  • SCHEME_OF_AMALGAMATION
  • Credit_Rating
  • Code_Of_Conduct

Annual Report 2009-2010

Annual Report 2010-2011

Annual Report 2011-2012

Annual Report 2012-2013

Annual Report 2013-2014

EGM Notice-LPL

E.G.M. SCRUTINIZER’S REPORT

Annual Report 2014-2015

AGM-2015 Notice

SCRUTINIZER’S REPORT A.G.M.-2015

Annual Report 2015-2016

AGM 2015-2016 Notice

Annual Report 2016-2017

AGM 2016-2017 Notice

Annual Report 2017-2018

AGM-2018 Notice

Annual Report 2018-2019

AGM-2019 Notice

Annual Report 2019-2020

AGM-2020 Notice

Scrutinizer and evoting Report-AGM 2020

AGM Transcript 2019-20

Quarter ended Mar'11

Quarter ended Jun'11

Quarter ended Sep'11

Quarter ended Dec'11

Quarter ended Mar'12

Quarter ended Jun'12

Quarter ended Sep'12

Quarter ended Dec'12

Quarter ended Mar'13

Quarter ended June'13

Quarter ended Sep'13

Quarter ended Dec'13

Quarter ended Mar'14

Quarter ended Jun'14

Quarter ended Sep'14

Quarter ended Dec'14

Quarter ended Mar'15

Quarter ended Jun'15

Quarter ended Sep'15

Quarter ended Dec'15

Quarter ended Mar'16

Quarter ended Jun'16

Quarter ended Sep'16

Shareholding Pattern-27-10-2016

Quarter ended Dec'16

Quarter ended Mar'17

Quarter ended Jun'17

Quarter ended Sep'17

Quarter ended Dec'17

Quarter ended Mar'18

Quarter ended Jun'18

Quarter ended Sep'18

Quarter ended Dec'18

Quarter ended Mar'19

Quarter ended Jun'19

Quarter ended Sep'19

Quarter ended Dec'19

Quarter ended Mar'20

Quarter ended Mar'20 and Full Year 2020

Quarter ended Jun'20

Quarter ended Sep'20

Quarter ended Mar'11

Quarter ended Jun'11

Quarter ended Jun'12

Quarter ended Sep'11

Quarter Ended Sep'12

Quarter ended Dec'11

Quarter Ended Mar'12

Quarter Ended Dec'12

Quarter Ended Mar'13

Quarter Ended Jun'13

Quarter Ended Sep'13

Quarter Ended Dec'13

Quarter Ended Mar'14

Quarter Ended Jun'14

Quarter Ended Sep'14

Quarter Ended Dec'14

Quarter Ended Mar'15

Quarter Ended Jun'15

Quarter Ended Sep'15

Quarter Ended Dec'15

Quarter Ended Mar'16

Quarter Ended Jun'16

Quarter Ended Sep'16

Quarter Ended Dec'16

Quarter Ended Mar'17

Quarter Ended Jun'17

Quarter Ended Sep'17

Quarter Ended Dec'17

Quarter Ended Mar'18

Quarter Ended Jun'18

Quarter Ended Sep'18

Quarter Ended Dec'18

Quarter Ended Mar'19

Quarter Ended Jun'19

Quarter Ended Sep'19

Quarter Ended Dec'19

Quarter Ended Mar'20

Quarter Ended Jun'20

Quarter Ended Sep'20

Quarter Ended Dec'20

Quarter ended Mar'11

Quarter ended Sep'11

Quarter ended Sep'11

Quarter ended Dec'11

Quarter ended Mar'12

Quarter ended Jun'12

Quarter ended Sep'12

Quarter ended Dec'12

Quarter ended Mar'13

Quarter ended June'13

Quarter ended Sep'13

Quarter ended Dec'13

Quarter ended Mar'14

Quarter ended Jun'14

Quarter ended Sep'14

Quarter ended Dec'14

Quarter ended Mar'15

Quarter ended Jun'15

Quarter ended Sep'15

Quarter ended Dec'15

Quarter ended Mar'16

Quarter ended June'16

Quarter ended Sept'16

Quarter ended Dec'16

Quarter ended Mar'17

Quarter ended Jun'17

Quarter ended Sep'17

Quarter ended Dec'17

Quarter ended Mar'18

Quarter ended Jun'18

Quarter ended Sep'18

Quarter ended Dec'18

Quarter ended Mar'19

Quarter ended Jun'19

Quarter ended Sep'19

Quarter ended Dec'19

Quarter ended Jun'20

Corporate Governance

Corporate Social Responsibility Policy

Nomination and Remuneration Policy

Performance Evaluation of the Directors

Performance Evaluation of the Independent Directors

Policy on Related Party Transactions

Vigil Mechanism - Whistle Blower Policy

Archival Policy

Policy on Disclosure of Material Event

COMPOSITION OF COMMITTEES

Details of KMP for Determining Materiality of Events

Policy on Familiarisation Programme of Independent Directors

NOTICE OF BOARD MEETING

NOTICE OF BOARD MEETING 30/05/2016

NOTICE OF BOARD MEETING 11/08/2016

Intimation of Board Meeting-10-11-2016

Intimation Regarding Board Meeting of Lincoln Pharma-27-10-2016

NOTICE OF BOARD MEETING

Notice of Board Meeting held on 30.05.17

Notice for Financial Result for the Quarter Ended on June 30, 2017

Intimation Regarding Board Meeting of Lincoln Pharma-23-01-2018

Intimation Regarding Board Meeting of Lincoln Pharma-30-05-2018

Intimation Regarding Board Meeting of Lincoln Pharma-14-08-2018

Intimation Regarding Board Meeting of Lincoln Pharma-14-11-2018

Intimation Regarding Board Meeting of Lincoln Pharma-12-02-2019

Intimation Regarding Board Meeting of Lincoln Pharma-30-05-2019

Intimation Regarding Board Meeting of Lincoln Pharma-14-08-2019

Intimation Regarding Board Meeting of Lincoln Pharma-19-09-2019

Intimation Regarding Board Meeting of Lincoln Pharma-14-11-2019

Intimation Regarding Board Meeting of Lincoln Pharma- 13-02-2020

Intimation Regarding Board Meeting of Lincoln Pharma- 27-02-2020

Intimation Regarding Board Meeting dated 25-06-2020

Intimation Regarding Board Meeting dated 20-08-2020

Intimation regarding Board Meeting Dated 03-11-2020

Intimation regarding Board Meeting Dated 02-02-2021

Zullinc Healthcare LLP-Annual Report- 2015-16

Lincoln Parenteral Limited-Annual Report- 2015-16

Zullinc Healthcare LLP-Annual Report- 2016-17

Lincoln Parenteral Limited-Annual Report- 2016-17

Lincoln Parenteral Limited-Annual Report- 2017-18

Zullinc Healthcare LLP- Annual Report 2017-2018

Savebux Finance & Investment Private Limited Annual Report 2017-18

Savebux Enterprise Pvt. Ltd. Annual Report 2018-19

Lincoln Parenteral Limited-Annual Report- 2018-19

Zullinc Healthcare LLP- Annual Report 2018-2019

Lincoln Parenteral Limited-Annual Report-2019-20

FOR FINANCIAL YEAR 2010-2011

FOR FINANCIAL YEAR 2011-2012

FOR FINANCIAL YEAR 2012-2013

FOR FINANCIAL YEAR 2013-2014

FOR FINANCIAL YEAR 2014-2015

FOR FINANCIAL YEAR 2015-2016

FOR FINANCIAL YEAR 2016-2017

FOR FINANCIAL YEAR 2017-2018

FOR FINANCIAL YEAR 2018-2019

LPL 2015-16 , Qtr.-1 Business Presentation

LPL 2015-16 , Qtr.-2 Business Presentation

LPL 2015-16 , Qtr.-3 Business Presentation

LPL 2015-16 , Qtr.-4 Business Presentation

LPL 2016-17 , Qtr.-1 Business Presentation

LPL 2016-17 , Qtr.-2 Business Presentation

LPL 2016-17 , Qtr.-3 Business Presentation

LPL 2016-17 , Qtr.-4 Business Presentation

LPL 2017-18 , Qtr.-1 Business Presentation

LPL 2017-18 , Qtr.-2 Business Presentation

LPL 2017-18 , Qtr.-3 Business Presentation

LPL 2017-18 , Qtr.-4 Business Presentation

LPL 2018-19 , Qtr.-1 Business Presentation

LPL 2018-19 , Qtr.-2 Business Presentation

LPL 2018-19 , Qtr.-3 Business Presentation

LPL 2018-19 , Qtr.-4 Business Presentation

LPL 2019-20 , Qtr.-1 Business Presentation

LPL 2019-20 , Qtr.-2 Business Presentation

LPL 2019-20 , Qtr.-3 Business Presentation

LPL 2019-20 , Qtr.-4 & Full year Business Presentation

LPL 2020-21 , Qtr.-1 Business Presentation

LPL 2020-21 , Qtr.-2 Business Presentation

LPL 2020-21 , Qtr.-3 Business Presentation

IEPF Suspense Account 2017

IEPF Suspense Account 2018

IEPF Suspense Account 2019

Prior Intimation to stock Exchange for Approve Draft Scheme of Ammalgamation

Outcome of Board Meeting of Scheme of Amalgamation

Audited Financials of Transferor & Transferee Cos.

Independent Auditor’s Certificate

Compliance Report

Draft Scheme of Amalgamation

Fairness Opinion by Merchant Banker

Shareholding Pattern of Transferor & Transferee Cos.

Report from the Audit Committee

Valuation Report from Independent Chartered Accountant

Observation Letter from the Stock Exchanges

NCLT Order Dated Sept 17 2020

Notice to the Members of Lincoln Pharma-NCLT conveyed

Notice to the Members of Lincoln Parenteral-NCLT conveyed

Notice to the Secured Creditors of Lincoln Parenteral

Notice to the Un-Secured Creditors of Lincoln Parenteral

Voting Result & Scrutinizers’ Report of NCLT Meeting-Lincoln Pharmaceuticals Limited

Scrutinizers’ Report of NCLT Meeting of Un-Secured Creditors-Lincoln Parenteral Ltd

Scrutinizers’ Report of NCLT Meeting of Members-Lincoln Parenteral Ltd

Scrutinizers’ Report of NCLT Meeting of Secured Creditors-Lincoln Parenteral Ltd

Chairman Report of the Meeting of the Un-Secured Creditors of Lincoln Parenteral Limited

Chairman Report of the Meeting of the Secured Creditors of Lincoln Parenteral Limited

Chairman Report of the Meeting of the Equity Shareholders of Lincoln Pharmaceuticals Limited

Chairman Report of the Meeting of the Equity Shareholders of Lincoln Parenteral Limited

Credit Rating

Credit Rating 2020-21

Code of Conduct for Insiders Trading-LPL

Code of Conduct

Code of Practices and Procedures For Fair Disclosure of Unpublished Price Sensitive Information

Would you like an Appointment? Schedule Request

About Us

To embark on a journey of success one needs the tools of preparedness, foresight and strategy. These lead to the path of growth and high quality operation.

Readmore

Quick Nav

  • Research & Development
  • Career
  • Inquiry
  • Feedback
  • Investors
  • Contact

Help / Customer Service

  • Faq
  • Site Map
  • Testimonials

Follow us

  • Facebook
  • Twitter
  • Youtube
  • Employee Area
© 2015 Lincoln Pharmaceuticals, Ahmedabad. All rights reserved